Correction to: Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register (Diabetologia, (2018), 61, 3, (599-606), 10.1007/s00125-017-4532-8);Short-term progression of cardiometabolic risk factors in relation to age at type 2 diabetes diagnosis: a longitudinal observational study of 100,606 individuals from the Swedish National Diabetes Register

Diabetologia

Volumn 61, Issue 3, 2018, Pages 599-606

  Steinarsson, Andri O ^a   Rawshani, Araz ^b   Gudbjörnsdottir, Soffia ^b,c   Franzén, Stefan ^c   Svensson, Ann Marie ^c   Sattar, Naveed ^d  

^a UNIVERSITY OF ICELAND   (Iceland)

^b UNIVERSITY OF GOTHENBURG   (Sweden)

^c National Diabetes Register   (Sweden)

^d UNIVERSITY OF GLASGOW   (United Kingdom)

Author keywords

Age group; Blood glucose; BMI; Cardiometabolic risk; Cardiovascular disease; Lipids; Premature mortality; Type 2 diabetes

Indexed keywords

ANTIHYPERTENSIVE AGENT; GLUCOSE; HEMOGLOBIN A1C; HIGH DENSITY LIPOPROTEIN CHOLESTEROL; HYDROXYMETHYLGLUTARYL COENZYME A REDUCTASE INHIBITOR; INSULIN; LIPID; LOW DENSITY LIPOPROTEIN CHOLESTEROL; ORAL ANTIDIABETIC AGENT; TRIACYLGLYCEROL; ANTIDIABETIC AGENT; CHOLESTEROL; GLYCOSYLATED HEMOGLOBIN;

ADULT; AGE; AGED; ARTICLE; BLOOD PRESSURE; BODY MASS; CARDIOMETABOLIC RISK; CHOLESTEROL BLOOD LEVEL; CLINICAL FEATURE; COHORT ANALYSIS; DIABETIC PATIENT; EDUCATIONAL STATUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEART PROTECTION; HEMOGLOBIN BLOOD LEVEL; HUMAN; ILLNESS TRAJECTORY; INSULIN TREATMENT; KIDNEY FUNCTION; LIPID BLOOD LEVEL; LONGITUDINAL STUDY; MAJOR CLINICAL STUDY; MALE; MARRIAGE; MIDDLE AGED; NON INSULIN DEPENDENT DIABETES MELLITUS; OBSERVATIONAL STUDY; PHARMACEUTICAL CARE; PRIORITY JOURNAL; REGISTER; SMOKING; SWEDEN; TRIACYLGLYCEROL BLOOD LEVEL; ALBUMINURIA; BLOOD; PHYSIOLOGY; RISK FACTOR;

AGED; ALBUMINURIA; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; FEMALE; GLYCATED HEMOGLOBIN A; HUMANS; HYPOGLYCEMIC AGENTS; LONGITUDINAL STUDIES; MALE; MIDDLE AGED; RISK FACTORS; SWEDEN;

EID: 85040257110     PISSN: 0012186X     EISSN: 14320428     Source Type: Journal    
DOI: 10.1007/s00125-019-04992-w     Document Type: Erratum

References (32)

1. González ELM, Johansson S, Wallander M-A, Rodríguez LAG (2009) Trends in the prevalence and incidence of diabetes in the UK: 1996-2005. J Epidemiol Community Health 63:332–336
2. Mokdad AH, Ford ES, Bowman BA et al (2000) Diabetes trends in the U.S.: 1990-1998. Diabetes Care 23:1278–1283
3. Alberti G, Zimmet P, Shaw J et al (2004) Type 2 diabetes in the young: the evolving epidemic: the International Diabetes Federation Consensus Workshop. Diabetes Care 27:1798–1811
4. Koopman RJ, Mainous AG, Diaz VA, Geesey ME (2005) Changes in age at diagnosis of type 2 diabetes mellitus in the United States, 1988 to 2000. Ann Fam Med 3:60–63
5. Grinstein G, Muzumdar R, Aponte L et al (2003) Presentation and 5-year follow-up of type 2 diabetes mellitus in African-American and Caribbean-Hispanic adolescents. Horm Res 60:121–126
6. Mokdad AH, Serdula MK, Dietz WH et al (1999) The spread of the obesity epidemic in the United States, 1991-1998. JAMA 282:1519–1522
7. Hillier TA, Pedula KL (2003) Complications in young adults with early-onset type 2 diabetes: losing the relative protection of youth. Diabetes Care 26:2999–3005
8. Gordon-Dseagu VLZ, Shelton N, Mindell J (2014) Diabetes mellitus and mortality from all-causes, cancer, cardiovascular and respiratory disease: evidence from the Health Survey for England and Scottish Health Survey cohorts. J Diabetes Complicat 28:791–797
9. Jansson SPO, Andersson DKG, Svärdsudd K (2016) Mortality and cardiovascular disease outcomes among 740 patients with new-onset type 2 diabetes detected by screening or clinically diagnosed in general practice. Diabet Med 33:324–331
10. Bell RA, Mayer-Davis EJ, Beyer JW et al (2009) Diabetes in non-Hispanic white youth: prevalence, incidence, and clinical characteristics: the SEARCH for Diabetes in Youth Study. Diabetes Care 32(Suppl 2):S102–S111
11. Eppens MC, Craig ME, Cusumano J et al (2006) Prevalence of diabetes complications in adolescents with type 2 compared with type 1 diabetes. Diabetes Care 29:1300–1306
12. Zeitler P, Hirst K, Pyle L et al (2012) A clinical trial to maintain glycemic control in youth with type 2 diabetes. N Engl J Med 366:2247–2256
13. Tancredi M, Rosengren A, Svensson A-M et al (2015) Excess mortality among persons with type 2 diabetes. N Engl J Med 373:1720–1732
14. Wong J, Constantino M, Yue DK (2015) Morbidity and mortality in young-onset type 2 diabetes in comparison to type 1 diabetes: where are we now? Curr Diab Rep 15:566
15. Eliasson B, Gudbjörnsdottir S (2014) Diabetes care – improvement through measurement. Diabetes Res Clin Pract 106:S291–S294
16. Rawshani A, Landin-Olsson M, Svensson AM et al (2014) The incidence of diabetes among 0-34 year olds in Sweden: new data and better methods. Diabetologia 57:1375–1381
17. WHO (2006) Definition and diagnosis of diabetes mellitus and intermediate hyperglycemia: report of a WHO/IDF consultation. Available at: www.who.int/diabetes/publications/diagnosis_diabetes2006/en/. Accessed 11 Oct 2017
18. Hoelzel W, Weykamp C, Jeppsson JO et al (2004) IFCC reference system for measurement of hemoglobin A1c in human blood and the national standardization schemes in the United States, Japan, and Sweden: a method-comparison study. Clin Chem 50:166–174
19. Huo X, Gao L, Guo L et al (2016) Risk of non-fatal cardiovascular diseases in early-onset versus late-onset type 2 diabetes in China: a cross-sectional study. Lancet Diabetes Endocrinol 4:115–124
20. Wright AK, Kontopantelis E, Emsley R et al (2017) Life expectancy and cause-specific mortality in type 2 diabetes: a population-based cohort study quantifying relationships in ethnic subgroups. Diabetes Care 40:338–345
21. Emerging Risk Factors Collaboration, SRK S, Kaptoge S et al (2011) Diabetes mellitus, fasting glucose, and risk of cause-specific death. N Engl J Med 364:829–841
22. Hatunic M, Burns N, Finucane F et al (2005) Contrasting clinical and cardiovascular risk status between early and later onset type 2 diabetes. Diab Vasc Dis Res 2:73–75
23. Hillier TA, Pedula KL (2001) Characteristics of an adult population with newly diagnosed type 2 diabetes: the relation of obesity and age of onset. Diabetes Care 24:1522–1527
24. Stratton IM, Adler AI, Neil HA et al (2000) Association of glycaemia with macrovascular and microvascular complications of type 2 diabetes (UKPDS 35): prospective observational study. BMJ 321:405–412
25. Niskanen L, Turpeinen A, Penttilä I, Uusitupa MIJ (1998) Hyperglycemia and compositional lipoprotein abnormalities as predictors of cardiovascular mortality in type 2 diabetes: a 15-year follow-up from the time of diagnosis. Diabetes Care 21:1861–1869
26. Aguilar-Salinas CA, Rojas R, Gómez-Pérez FJ et al (2002) Prevalence and characteristics of early-onset type 2 diabetes in Mexico. Am J Med 113:569–574
27. Triglyceride Coronary Disease Genetics Consortium and Emerging Risk Factors Collaboration, Sarwar N, Sandhu MS et al (2010) Triglyceride-mediated pathways and coronary disease: collaborative analysis of 101 studies. Lancet 375:1634–1639
28. Navar-Boggan AM, Peterson ED, D’Agostino RB et al (2015) Hyperlipidemia in early adulthood increases long-term risk of coronary heart disease. Circulation 131:451–458
29. JBS3 Board (2014) Joint British Societies’ consensus recommendations for the prevention of cardiovascular disease (JBS3). Heart 100:ii1-ii67
30. Song SH, Hardisty CA (2009) Early onset type 2 diabetes mellitus: a harbinger for complications in later years – clinical observation from a secondary care cohort. QJM 102:799–806
31. Sniderman AD, Thanassoulis G, Williams K, Pencina M (2016) Risk of premature cardiovascular disease vs the number of premature cardiovascular events. JAMA Cardiol 1:492–494
32. Logue J, Walker JJ, Colhoun HM et al (2011) Do men develop type 2 diabetes at lower body mass indices than women? Diabetologia 54:3003–3006